Recent Posts
- doceree
- CAR T-cell Therapy in CLL (chronic lymphocytic leukemia): Navigating the Landscape and Looking Ahead with Catherine Coombs, MD
- Advancing Acute Lymphoblastic Leukemia Treatment with CAR-T Cells: Insights from Dr. Anjali Advani
- Utility of ctDNA in CAR-T and bispecific therapy with Dr. Brian Sworder, MD
- Nitin Jain, MD Challenging case involving advanced B-cell lymphoblastic leukemia (BLL) from the CAR-T and Bispecifics Conference [2024]
Wishing a Happy Birthday to Jeffrey Weber MD today. So important to the field of Immunotherapy. An amazing friend, mentor, leader.
@nyulangone @sitcancer @ASCO @myESMO
VIDEO: CAR T-cell Therapy in CLL (chronic lymphocytic leukemia): Navigating the Landscape and Looking Ahead with Catherine Coombs, MD https://oncologytube.com/car-t-cell-therapy-in-cll-chronic-lymphocytic-leukemia-navigating-the-landscape-and-looking-ahead-with-catherine-coombs-md/ @UCIrvineHealth @_MDEducation @Ryan_fitzpatric
Oncology Conference Videos
Oncology News
By: Hatem Azim, MD Date. 12/08/2023At SABCS 2023, a discussion on fertility preservation and assisted reproductive…
Rabi Hanna, MD, from the Department of Pediatric Hematology Oncology and BMT at Cleveland Clinic…
In a discussion on cancer science, Wassim Mchayleh, MD, explores the role of Minimal Residual…
Allen Wilbanks stands at the forefront of SABCS 2023, the setting for a conversation with…
Jeff Sharman, MD, a medical oncologist at the Willamette Ballet Cancer Institute and Research Center,…
David J. Andorsky, MD, an Associate Chair for US Oncology Hematology Research and a member…
Asya Nina Varshavsky-Yanovsky, MD, PhD, serves as an Assistant Professor within the Department of Bone…
Allen Wilbanks finds himself at SABCS 2023, where he engages in a discussion with Dr.…
Zandra Klippel, MD, Global Product Head, Sanofi – Phase 3 IsKia trial of Sarclisa® (isatuximab)…
Allen Wilbanks stood alongside Alina Hamilton, PhD, at the SABCS 2023 event, where they delved…
… The Medical Oncology Association of Southern California (MOASC) 2024 Summit has once again set…